American Heart Journal
Volume 145, Issue 6 , Pages 993-998, June 2003

Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial☆

  • Edward P Havranek, MD

      Affiliations

    • Division of Cardiology, University of Colorado Health Sciences Center, Department of Medicine, Denver, Colo, USA
    • Denver Health and Hospitals, Denver, Colo, USA
    • Corresponding Author InformationReprint requests: Edward P. Havranek, MD, Denver Health Medical Center #0960, 777 Bannock St, Denver, CO 80204-4507, USA.
    • ,
  • Anne Esler, PhD

      Affiliations

    • Colorado Prevention Center, Denver, Colo, USA
    • ,
  • Raymond O Estacio, MD

      Affiliations

    • Division of General Internal Medicine, University of Colorado Health Sciences Center, Department of Medicine, Denver, Colo, USA,
    • Colorado Prevention Center, Denver, Colo, USA
    • Denver Health and Hospitals, Denver, Colo, USA
    • ,
  • Philip S Mehler, MD

      Affiliations

    • Division of General Internal Medicine, University of Colorado Health Sciences Center, Department of Medicine, Denver, Colo, USA,
    • Colorado Prevention Center, Denver, Colo, USA
    • Denver Health and Hospitals, Denver, Colo, USA
    • ,
  • Robert W Schrier, MD

      Affiliations

    • Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Department of Medicine, Denver, Colo, USA
    • Colorado Prevention Center, Denver, Colo, USA

Received 9 April 2002; accepted 25 July 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by the Bayer Pharmaceutical Company and the National Institute of Diabetes and Digestive and Kidney Diseases (DK50298-02).

PII: S0002-8703(02)94780-0

doi:10.1016/S0002-8703(02)94780-0

American Heart Journal
Volume 145, Issue 6 , Pages 993-998, June 2003

Article Tools